The sessions included “Modeling Reveals the Origin of Pathogenicity in a Glu to Asp Variant of a Serpin in Chronic Obstructive Pulmonary Disease” by Dr. Debnath Pai (Professor, Department of Computational and Databases, IISC Bangalore), “Immune Disorders and Cancer – A Pharmacogenomic Model for the Design of P4-Drugs” by Dr. P. K. Krishnan Namboori (Associate Professor, AMMAS Research Lab, Coimbatore), “Drug Design Strategies using Target Structure-based and Ligand-based Modeling: Case Studies” by Dr. P Yogeswari (Professor, Department of Pharmacy, BITS Pilani, Hyderabad Campus) and “Addressing Structure-based Drug Design towards Neuroimmunomodulatory Disorders” by Dr. Gopi Mohan C. (Associate Professor, Centre for Nanosciences and Molecular Medicine, AIMS, Kochi). Interactive sessions and hands-on training on molecular docking and ADMET were provided by Dr. Sudipa Mondal (NIT, Nagpur).
| Day | Sessions | Topic | Resource person |
| Day I | Session I | Modeling reveals the origin of pathogenicity in a Glu to Asp variant of a Serpin in Chronic obstructive pulmonary disease | Dr. Debnath Pai, Professor, Dept. of Computational and databases, IISC Bangalore |
| Session II | Immune disorders and cancer –a pharmacogenomic model for the design of P4-drugs | Dr. P. K. Krishnan Namboori, Associate Professor, AMMAS Research Lab, Coimbatore | |
| Session III | Drug design strategies using target structure based and ligand based modeling: case studies | Dr. P Yogeswari, Professor, Dept. of Pharmacy, BITS Pilani , Hyderabad campus | |
| Session II | Addressing structure based drug design towards neuroimmunomodulatory disorders | Dr. Gopi Mohan C, Associate Professor, Centre for Nanosciences and Molecular Medicine, AIMS, Kochi | |
| Day 2 | Session I | Interactive session and hands on training on molecular docking | Dr. Sudipa Mondal, NIT, Nagpur |
| Session II | Hand on training on Molecular Docking | ||
| Session III | ADMET hands on training | ||
| Day 3 | Session I | Hands on training on QSAR and Pharmacophore modeling | |
| Session II | FT-NMR, 2D NMR and DEPT. Interpretation of mass spectroscopy |
